Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Marketing HPV vaccine: implications for adolescent health and medical professionalism.

Rothman SM, Rothman DJ.

JAMA. 2009 Aug 19;302(7):781-6. doi: 10.1001/jama.2009.1179.

PMID:
19690311
2.

Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.

Vetter KM, Geller SE.

J Womens Health (Larchmt). 2007 Nov;16(9):1258-68. Review.

PMID:
18001182
3.

The quadrivalent human papillomavirus vaccine: potential factors in effectiveness.

Zonfrillo NJ, Hackley B.

J Midwifery Womens Health. 2008 May-Jun;53(3):188-94. doi: 10.1016/j.jmwh.2007.12.015. Review.

PMID:
18455092
6.

Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.

McIntosh J, Sturpe DA, Khanna N.

J Am Pharm Assoc (2003). 2008 Jan-Feb;48(1):e1-13; quiz e14-7. doi: 10.1331/JAPhA/2008.07032. Review.

PMID:
18192123
7.

Prevention strategies against the human papillomavirus: the effectiveness of vaccination.

Stanley M.

Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S19-23. Review.

PMID:
17938013
8.

Barriers to human papillomavirus vaccine acceptability in Israel.

Fisher WA, Laniado H, Shoval H, Hakim M, Bornstein J.

Vaccine. 2013 Nov 22;31 Suppl 8:I53-7. doi: 10.1016/j.vaccine.2013.06.107. Review.

PMID:
24229720
9.

Current status of human papillomavirus vaccination.

Brotherton JM, Ogilvie GS.

Curr Opin Oncol. 2015 Sep;27(5):399-404. doi: 10.1097/CCO.0000000000000211. Review.

PMID:
26258273
10.

Clinical cancer chemoprevention: From the hepatitis B virus (HBV) vaccine to the human papillomavirus (HPV) vaccine.

Tsai HJ.

Taiwan J Obstet Gynecol. 2015 Apr;54(2):112-5. doi: 10.1016/j.tjog.2013.11.009. Review.

11.

Human papillomavirus vaccines: an update for gynecologists.

Ault KA.

Clin Obstet Gynecol. 2008 Sep;51(3):527-32. doi: 10.1097/GRF.0b013e31818092df. Review.

PMID:
18677145
12.

Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.

Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.

Pharmacotherapy. 2011 Mar;31(3):280-97. doi: 10.1592/phco.31.3.280. Review.

PMID:
21361739
13.

Can male vaccination reduce the burden of human papillomavirus-related disease in the United States?

Low GM, Attiga YS, Garg G, Schlegal R, Gallicano GI.

Viral Immunol. 2012 Jun;25(3):174-86. doi: 10.1089/vim.2011.0083. Review. Erratum in: Viral Immunol. 2012 Aug;25(4):345.

PMID:
22691099
14.

Human papillomavirus vaccine: a paradigm shift for pediatricians.

Jenson HB.

Curr Opin Pediatr. 2009 Feb;21(1):112-21. doi: 10.1097/MOP.0b013e3283207f93. Review.

PMID:
19242247
15.

[Vaccines against human papillomavirus (HPV); between registration and implementation].

van Rossum TG, de Melker HE, Houweling H, Voordouw AC, Meijer CJ, Helmerhorst TJ, Kretzschmar M, Berkhof J, van der Noordaa J.

Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):987-92. Review. Dutch.

PMID:
18549172
16.

Quadrivalent human papillomavirus vaccine.

Barr E, Tamms G.

Clin Infect Dis. 2007 Sep 1;45(5):609-7. Epub 2007 Jul 25. Review.

PMID:
17682997
17.

Decreasing risk: impact of HPV vaccination on outcomes.

Hymel PA.

Am J Manag Care. 2006 Dec;12(17 Suppl):S473-83. Review.

18.

Predictors of HPV vaccine acceptability: a theory-informed, systematic review.

Brewer NT, Fazekas KI.

Prev Med. 2007 Aug-Sep;45(2-3):107-14. Epub 2007 Jun 2. Review.

PMID:
17628649
19.

The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.

Sheinfeld Gorin SN, Glenn BA, Perkins RB.

Adv Ther. 2011 Aug;28(8):615-39. doi: 10.1007/s12325-011-0045-x. Epub 2011 Aug 1. Review.

PMID:
21818672
20.

Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.

Harper DM.

Public Health Genomics. 2009;12(5-6):319-30. doi: 10.1159/000214922. Epub 2009 Aug 11. Review.

PMID:
19684444

Supplemental Content

Support Center